GlassScriptPhysician profile
David A Kelly
NPI 1821259722
$2,145.44
in general payments reported to CMS, 2019-2025
23 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $42.93 · 2021: $314 · 2022: $476 · 2023: $133 · 2024: $501 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $809.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $497.40 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Regeneron Healthcare Solutions, INC. | $299.97 | 2023-2025 | Dupixent, Libtayo |
| Amgen INC. | $276.08 | 2021-2024 | Otezla |
| Organogenesis INC. | $179.71 | 2022-2024 | Puraply |
| Leo Pharma INC. | $148.33 | 2022-2025 | Adbry |
| Celgene Corporation | $131.72 | 2019 | |
| Galderma Laboratories, L.P. | $100.30 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $72.46 | 2019-2024 | |
| Smith+Nephew, INC. | $69.07 | 2022 | |
| Kyowa Kirin, INC. | $53.58 | 2025 | |
| Sun Pharmaceutical Industries INC. | $45.63 | 2022-2024 | |
| Genentech USA, INC. | $41.82 | 2021-2022 | |
| Genzyme Corporation | $35.71 | 2021-2024 | |
| Lilly USA, LLC | $24.80 | 2024 | Taltz, Olumiant |
| Davol INC. | $23.84 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $22.68 | 2019 | |
| Abbvie INC. | $21.37 | 2025 | |
| Misonix INC | $20.44 | 2021 | |
| Janssen Biotech, INC. | $19.20 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.73 | 2025 | Jublia |
| Biowound Solutions, INC. | $15.30 | 2025 | Bio-Connekt |
| Nabriva Therapeutics, Plc | $13.67 | 2022 | |
| Endo Pharmaceuticals INC. | $13.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.